Products: Primary Antibodies
PRODUCT OPTIONS
★ Trial Size Available ★Brand | Catalog # | Option | Volume | Concentration | Price | |
---|---|---|---|---|---|---|
Brand![]() |
Catalog # 75-240 |
Option Purified |
Volume 100 µL |
Concentration 1 mg/mL |
Price $335.00 |
|
Brand![]() |
Catalog # 75-240-020 |
Option Purified Trial-Size |
Volume 20 µL |
Concentration 1 mg/mL |
Price $119.00 |
|
Brand![]() |
Catalog # 73-240 |
Option TC Supernatant |
Volume 5 mL |
Concentration Lot dependent |
Price $335.00 |
Product Details
Monoclonal
Mouse
IgG1
Human Mouse Rat
ICC IHC WB
Glial fibrillary acidic protein (GFAP) is an intermediate filament with many different isoforms, and acts as a structural protein in the cytoskeleton. It is expressed in astrocytes in brain and is often used as an astrocyte marker. GFAP is belived to be involved in many CNS processes including cell communication and mitosis. GFAP has been found to be involved in Alexander disease and Wernicke's encephalopathy.
Synthetic peptide amino acids 411-422 (KTVEMRDGEVIK) of human GFAP (also known as Glial fibrillary acidic protein, accession number P14136); Rat: 100% identity (12/12 amino acids identical); Mouse: 100% identity (12/12 amino acids identical)
Greater than 50% identity with other proteins (Vimentin, Desmin, Tumor protein p73 and Peripherin)
Cross-reacts with GFAP-R416W and other GFAP mutant proteinsDoes not cross-react with other proteins (based on KO validation results)
GFAP
GFAP
Purified: AB_10672299
Purified Trial-Size: AB_10672299
TC Supernatant: AB_10672298
Antibody Validation and Application Notes
This antibody has been validated using the following assays:
This antibody has been knockout-validated in mouse brain (by Western blot and/or immunohistochemistry).
This antibody recognizes a single immunoreactive band of expected molecular weight when used to probe brain lysate.
This antibody shows the expected staining pattern when used to stain COS cells overexpressing target.
50 kDa
Quality Control
The following quality control assay is performed on each new lot of this antibody to ensure it meets designated performance requirements.
Each new lot of this antibody is tested to confirm that it recognizes a single immunoreactive band of expected molecular weight when used to probe brain lysate.